Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

CBRNE Defense Market

ID: MRFR/AD/27293-HCR
128 Pages
Shubham Munde
Last Updated: April 06, 2026

CBRNE Defense Market Size, Share, Industry Trend & Analysis Research Report By System Type (Detection, Protection, Decontamination), By Equipment Type (Portable, Vehicle-Mounted, Fixed), By Chemical or Biological Agent Type (Chemical Warfare Agents, Biological Warfare Agents, Radiological Warfare Agents), By Application (Military, Law Enforcement, Emergency Response, Critical Infrastructure), By End-User Type (Government, Commercial) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

CBRNE Defense Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Aerospace & Defense, BY System Type (USD Billion)
  49.     4.1.1 Detection
  50.     4.1.2 Protection
  51.     4.1.3 Decontamination
  52.   4.2 Aerospace & Defense, BY Equipment Type (USD Billion)
  53.     4.2.1 Portable
  54.     4.2.2 Vehicle-Mounted
  55.     4.2.3 Fixed
  56.   4.3 Aerospace & Defense, BY Chemical or Biological Agent Type (USD Billion)
  57.     4.3.1 Chemical Warfare Agents
  58.     4.3.2 Biological Warfare Agents
  59.     4.3.3 Radiological Warfare Agents
  60.   4.4 Aerospace & Defense, BY Application (USD Billion)
  61.     4.4.1 Military
  62.     4.4.2 Law Enforcement
  63.     4.4.3 Emergency Response
  64.     4.4.4 Critical Infrastructure
  65.   4.5 Aerospace & Defense, BY End-User Type (USD Billion)
  66.     4.5.1 Government
  67.     4.5.2 Commercial
  68.   4.6 Aerospace & Defense, BY Region (USD Billion)
  69.     4.6.1 North America
  70.       4.6.1.1 US
  71.       4.6.1.2 Canada
  72.     4.6.2 Europe
  73.       4.6.2.1 Germany
  74.       4.6.2.2 UK
  75.       4.6.2.3 France
  76.       4.6.2.4 Russia
  77.       4.6.2.5 Italy
  78.       4.6.2.6 Spain
  79.       4.6.2.7 Rest of Europe
  80.     4.6.3 APAC
  81.       4.6.3.1 China
  82.       4.6.3.2 India
  83.       4.6.3.3 Japan
  84.       4.6.3.4 South Korea
  85.       4.6.3.5 Malaysia
  86.       4.6.3.6 Thailand
  87.       4.6.3.7 Indonesia
  88.       4.6.3.8 Rest of APAC
  89.     4.6.4 South America
  90.       4.6.4.1 Brazil
  91.       4.6.4.2 Mexico
  92.       4.6.4.3 Argentina
  93.       4.6.4.4 Rest of South America
  94.     4.6.5 MEA
  95.       4.6.5.1 GCC Countries
  96.       4.6.5.2 South Africa
  97.       4.6.5.3 Rest of MEA
  98. 5 SECTION V: COMPETITIVE ANALYSIS
  99.   5.1 Competitive Landscape
  100.     5.1.1 Overview
  101.     5.1.2 Competitive Analysis
  102.     5.1.3 Market share Analysis
  103.     5.1.4 Major Growth Strategy in the Aerospace & Defense
  104.     5.1.5 Competitive Benchmarking
  105.     5.1.6 Leading Players in Terms of Number of Developments in the Aerospace & Defense
  106.     5.1.7 Key developments and growth strategies
  107.       5.1.7.1 New Product Launch/Service Deployment
  108.       5.1.7.2 Merger & Acquisitions
  109.       5.1.7.3 Joint Ventures
  110.     5.1.8 Major Players Financial Matrix
  111.       5.1.8.1 Sales and Operating Income
  112.       5.1.8.2 Major Players R&D Expenditure. 2023
  113.   5.2 Company Profiles
  114.     5.2.1 Northrop Grumman (US)
  115.       5.2.1.1 Financial Overview
  116.       5.2.1.2 Products Offered
  117.       5.2.1.3 Key Developments
  118.       5.2.1.4 SWOT Analysis
  119.       5.2.1.5 Key Strategies
  120.     5.2.2 Raytheon Technologies (US)
  121.       5.2.2.1 Financial Overview
  122.       5.2.2.2 Products Offered
  123.       5.2.2.3 Key Developments
  124.       5.2.2.4 SWOT Analysis
  125.       5.2.2.5 Key Strategies
  126.     5.2.3 BAE Systems (GB)
  127.       5.2.3.1 Financial Overview
  128.       5.2.3.2 Products Offered
  129.       5.2.3.3 Key Developments
  130.       5.2.3.4 SWOT Analysis
  131.       5.2.3.5 Key Strategies
  132.     5.2.4 L3Harris Technologies (US)
  133.       5.2.4.1 Financial Overview
  134.       5.2.4.2 Products Offered
  135.       5.2.4.3 Key Developments
  136.       5.2.4.4 SWOT Analysis
  137.       5.2.4.5 Key Strategies
  138.     5.2.5 Thales Group (FR)
  139.       5.2.5.1 Financial Overview
  140.       5.2.5.2 Products Offered
  141.       5.2.5.3 Key Developments
  142.       5.2.5.4 SWOT Analysis
  143.       5.2.5.5 Key Strategies
  144.     5.2.6 General Dynamics (US)
  145.       5.2.6.1 Financial Overview
  146.       5.2.6.2 Products Offered
  147.       5.2.6.3 Key Developments
  148.       5.2.6.4 SWOT Analysis
  149.       5.2.6.5 Key Strategies
  150.     5.2.7 Lockheed Martin (US)
  151.       5.2.7.1 Financial Overview
  152.       5.2.7.2 Products Offered
  153.       5.2.7.3 Key Developments
  154.       5.2.7.4 SWOT Analysis
  155.       5.2.7.5 Key Strategies
  156.     5.2.8 Chemring Group (GB)
  157.       5.2.8.1 Financial Overview
  158.       5.2.8.2 Products Offered
  159.       5.2.8.3 Key Developments
  160.       5.2.8.4 SWOT Analysis
  161.       5.2.8.5 Key Strategies
  162.     5.2.9 Battelle Memorial Institute (US)
  163.       5.2.9.1 Financial Overview
  164.       5.2.9.2 Products Offered
  165.       5.2.9.3 Key Developments
  166.       5.2.9.4 SWOT Analysis
  167.       5.2.9.5 Key Strategies
  168.   5.3 Appendix
  169.     5.3.1 References
  170.     5.3.2 Related Reports
  171. 6 LIST OF FIGURES
  172.   6.1 MARKET SYNOPSIS
  173.   6.2 NORTH AMERICA MARKET ANALYSIS
  174.   6.3 US MARKET ANALYSIS BY SYSTEM TYPE
  175.   6.4 US MARKET ANALYSIS BY EQUIPMENT TYPE
  176.   6.5 US MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  177.   6.6 US MARKET ANALYSIS BY APPLICATION
  178.   6.7 US MARKET ANALYSIS BY END-USER TYPE
  179.   6.8 CANADA MARKET ANALYSIS BY SYSTEM TYPE
  180.   6.9 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
  181.   6.10 CANADA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  182.   6.11 CANADA MARKET ANALYSIS BY APPLICATION
  183.   6.12 CANADA MARKET ANALYSIS BY END-USER TYPE
  184.   6.13 EUROPE MARKET ANALYSIS
  185.   6.14 GERMANY MARKET ANALYSIS BY SYSTEM TYPE
  186.   6.15 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
  187.   6.16 GERMANY MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  188.   6.17 GERMANY MARKET ANALYSIS BY APPLICATION
  189.   6.18 GERMANY MARKET ANALYSIS BY END-USER TYPE
  190.   6.19 UK MARKET ANALYSIS BY SYSTEM TYPE
  191.   6.20 UK MARKET ANALYSIS BY EQUIPMENT TYPE
  192.   6.21 UK MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  193.   6.22 UK MARKET ANALYSIS BY APPLICATION
  194.   6.23 UK MARKET ANALYSIS BY END-USER TYPE
  195.   6.24 FRANCE MARKET ANALYSIS BY SYSTEM TYPE
  196.   6.25 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
  197.   6.26 FRANCE MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  198.   6.27 FRANCE MARKET ANALYSIS BY APPLICATION
  199.   6.28 FRANCE MARKET ANALYSIS BY END-USER TYPE
  200.   6.29 RUSSIA MARKET ANALYSIS BY SYSTEM TYPE
  201.   6.30 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
  202.   6.31 RUSSIA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  203.   6.32 RUSSIA MARKET ANALYSIS BY APPLICATION
  204.   6.33 RUSSIA MARKET ANALYSIS BY END-USER TYPE
  205.   6.34 ITALY MARKET ANALYSIS BY SYSTEM TYPE
  206.   6.35 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
  207.   6.36 ITALY MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  208.   6.37 ITALY MARKET ANALYSIS BY APPLICATION
  209.   6.38 ITALY MARKET ANALYSIS BY END-USER TYPE
  210.   6.39 SPAIN MARKET ANALYSIS BY SYSTEM TYPE
  211.   6.40 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
  212.   6.41 SPAIN MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  213.   6.42 SPAIN MARKET ANALYSIS BY APPLICATION
  214.   6.43 SPAIN MARKET ANALYSIS BY END-USER TYPE
  215.   6.44 REST OF EUROPE MARKET ANALYSIS BY SYSTEM TYPE
  216.   6.45 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
  217.   6.46 REST OF EUROPE MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  218.   6.47 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  219.   6.48 REST OF EUROPE MARKET ANALYSIS BY END-USER TYPE
  220.   6.49 APAC MARKET ANALYSIS
  221.   6.50 CHINA MARKET ANALYSIS BY SYSTEM TYPE
  222.   6.51 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
  223.   6.52 CHINA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  224.   6.53 CHINA MARKET ANALYSIS BY APPLICATION
  225.   6.54 CHINA MARKET ANALYSIS BY END-USER TYPE
  226.   6.55 INDIA MARKET ANALYSIS BY SYSTEM TYPE
  227.   6.56 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
  228.   6.57 INDIA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  229.   6.58 INDIA MARKET ANALYSIS BY APPLICATION
  230.   6.59 INDIA MARKET ANALYSIS BY END-USER TYPE
  231.   6.60 JAPAN MARKET ANALYSIS BY SYSTEM TYPE
  232.   6.61 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
  233.   6.62 JAPAN MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  234.   6.63 JAPAN MARKET ANALYSIS BY APPLICATION
  235.   6.64 JAPAN MARKET ANALYSIS BY END-USER TYPE
  236.   6.65 SOUTH KOREA MARKET ANALYSIS BY SYSTEM TYPE
  237.   6.66 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
  238.   6.67 SOUTH KOREA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  239.   6.68 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  240.   6.69 SOUTH KOREA MARKET ANALYSIS BY END-USER TYPE
  241.   6.70 MALAYSIA MARKET ANALYSIS BY SYSTEM TYPE
  242.   6.71 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
  243.   6.72 MALAYSIA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  244.   6.73 MALAYSIA MARKET ANALYSIS BY APPLICATION
  245.   6.74 MALAYSIA MARKET ANALYSIS BY END-USER TYPE
  246.   6.75 THAILAND MARKET ANALYSIS BY SYSTEM TYPE
  247.   6.76 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
  248.   6.77 THAILAND MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  249.   6.78 THAILAND MARKET ANALYSIS BY APPLICATION
  250.   6.79 THAILAND MARKET ANALYSIS BY END-USER TYPE
  251.   6.80 INDONESIA MARKET ANALYSIS BY SYSTEM TYPE
  252.   6.81 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
  253.   6.82 INDONESIA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  254.   6.83 INDONESIA MARKET ANALYSIS BY APPLICATION
  255.   6.84 INDONESIA MARKET ANALYSIS BY END-USER TYPE
  256.   6.85 REST OF APAC MARKET ANALYSIS BY SYSTEM TYPE
  257.   6.86 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
  258.   6.87 REST OF APAC MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  259.   6.88 REST OF APAC MARKET ANALYSIS BY APPLICATION
  260.   6.89 REST OF APAC MARKET ANALYSIS BY END-USER TYPE
  261.   6.90 SOUTH AMERICA MARKET ANALYSIS
  262.   6.91 BRAZIL MARKET ANALYSIS BY SYSTEM TYPE
  263.   6.92 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
  264.   6.93 BRAZIL MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  265.   6.94 BRAZIL MARKET ANALYSIS BY APPLICATION
  266.   6.95 BRAZIL MARKET ANALYSIS BY END-USER TYPE
  267.   6.96 MEXICO MARKET ANALYSIS BY SYSTEM TYPE
  268.   6.97 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
  269.   6.98 MEXICO MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  270.   6.99 MEXICO MARKET ANALYSIS BY APPLICATION
  271.   6.100 MEXICO MARKET ANALYSIS BY END-USER TYPE
  272.   6.101 ARGENTINA MARKET ANALYSIS BY SYSTEM TYPE
  273.   6.102 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
  274.   6.103 ARGENTINA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  275.   6.104 ARGENTINA MARKET ANALYSIS BY APPLICATION
  276.   6.105 ARGENTINA MARKET ANALYSIS BY END-USER TYPE
  277.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SYSTEM TYPE
  278.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
  279.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  280.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  281.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER TYPE
  282.   6.111 MEA MARKET ANALYSIS
  283.   6.112 GCC COUNTRIES MARKET ANALYSIS BY SYSTEM TYPE
  284.   6.113 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
  285.   6.114 GCC COUNTRIES MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  286.   6.115 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  287.   6.116 GCC COUNTRIES MARKET ANALYSIS BY END-USER TYPE
  288.   6.117 SOUTH AFRICA MARKET ANALYSIS BY SYSTEM TYPE
  289.   6.118 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
  290.   6.119 SOUTH AFRICA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  291.   6.120 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  292.   6.121 SOUTH AFRICA MARKET ANALYSIS BY END-USER TYPE
  293.   6.122 REST OF MEA MARKET ANALYSIS BY SYSTEM TYPE
  294.   6.123 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
  295.   6.124 REST OF MEA MARKET ANALYSIS BY CHEMICAL OR BIOLOGICAL AGENT TYPE
  296.   6.125 REST OF MEA MARKET ANALYSIS BY APPLICATION
  297.   6.126 REST OF MEA MARKET ANALYSIS BY END-USER TYPE
  298.   6.127 KEY BUYING CRITERIA OF AEROSPACE & DEFENSE
  299.   6.128 RESEARCH PROCESS OF MRFR
  300.   6.129 DRO ANALYSIS OF AEROSPACE & DEFENSE
  301.   6.130 DRIVERS IMPACT ANALYSIS: AEROSPACE & DEFENSE
  302.   6.131 RESTRAINTS IMPACT ANALYSIS: AEROSPACE & DEFENSE
  303.   6.132 SUPPLY / VALUE CHAIN: AEROSPACE & DEFENSE
  304.   6.133 AEROSPACE & DEFENSE, BY SYSTEM TYPE, 2024 (% SHARE)
  305.   6.134 AEROSPACE & DEFENSE, BY SYSTEM TYPE, 2024 TO 2035 (USD Billion)
  306.   6.135 AEROSPACE & DEFENSE, BY EQUIPMENT TYPE, 2024 (% SHARE)
  307.   6.136 AEROSPACE & DEFENSE, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
  308.   6.137 AEROSPACE & DEFENSE, BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2024 (% SHARE)
  309.   6.138 AEROSPACE & DEFENSE, BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2024 TO 2035 (USD Billion)
  310.   6.139 AEROSPACE & DEFENSE, BY APPLICATION, 2024 (% SHARE)
  311.   6.140 AEROSPACE & DEFENSE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  312.   6.141 AEROSPACE & DEFENSE, BY END-USER TYPE, 2024 (% SHARE)
  313.   6.142 AEROSPACE & DEFENSE, BY END-USER TYPE, 2024 TO 2035 (USD Billion)
  314.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  315. 7 LIST OF TABLES
  316.   7.1 LIST OF ASSUMPTIONS
  317.     7.1.1
  318.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  319.     7.2.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  320.     7.2.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  321.     7.2.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  322.     7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  323.     7.2.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  324.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  325.     7.3.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  326.     7.3.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  327.     7.3.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  328.     7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
  329.     7.3.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  330.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  331.     7.4.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  332.     7.4.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  333.     7.4.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  334.     7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
  335.     7.4.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  336.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  337.     7.5.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  338.     7.5.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  339.     7.5.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  340.     7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
  341.     7.5.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  342.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  343.     7.6.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  344.     7.6.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  345.     7.6.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  346.     7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
  347.     7.6.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  348.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  349.     7.7.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  350.     7.7.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  351.     7.7.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  352.     7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
  353.     7.7.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  354.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  355.     7.8.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  356.     7.8.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  357.     7.8.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  358.     7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
  359.     7.8.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  360.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  361.     7.9.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  362.     7.9.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  363.     7.9.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  364.     7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
  365.     7.9.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  366.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  367.     7.10.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  368.     7.10.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  369.     7.10.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  370.     7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
  371.     7.10.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  372.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  373.     7.11.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  374.     7.11.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  375.     7.11.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  376.     7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
  377.     7.11.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  378.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  379.     7.12.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  380.     7.12.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  381.     7.12.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  382.     7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
  383.     7.12.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  384.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  385.     7.13.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  386.     7.13.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  387.     7.13.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  388.     7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
  389.     7.13.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  390.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  391.     7.14.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  392.     7.14.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  393.     7.14.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  394.     7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
  395.     7.14.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  396.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  397.     7.15.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  398.     7.15.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  399.     7.15.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  400.     7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
  401.     7.15.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  402.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  403.     7.16.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  404.     7.16.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  405.     7.16.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  406.     7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
  407.     7.16.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  408.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  409.     7.17.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  410.     7.17.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  411.     7.17.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  412.     7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
  413.     7.17.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  414.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  415.     7.18.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  416.     7.18.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  417.     7.18.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  418.     7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
  419.     7.18.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  420.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  421.     7.19.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  422.     7.19.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  423.     7.19.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  424.     7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
  425.     7.19.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  426.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  427.     7.20.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  428.     7.20.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  429.     7.20.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  430.     7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
  431.     7.20.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  432.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  433.     7.21.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  434.     7.21.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  435.     7.21.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  436.     7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
  437.     7.21.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  438.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  439.     7.22.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  440.     7.22.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  441.     7.22.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  442.     7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
  443.     7.22.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  444.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  445.     7.23.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  446.     7.23.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  447.     7.23.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  448.     7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
  449.     7.23.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  450.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  451.     7.24.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  452.     7.24.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  453.     7.24.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  454.     7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
  455.     7.24.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  456.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  457.     7.25.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  458.     7.25.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  459.     7.25.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  460.     7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
  461.     7.25.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  462.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  463.     7.26.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  464.     7.26.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  465.     7.26.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  466.     7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
  467.     7.26.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  468.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  469.     7.27.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  470.     7.27.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  471.     7.27.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  472.     7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
  473.     7.27.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  474.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  475.     7.28.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  476.     7.28.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  477.     7.28.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  478.     7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
  479.     7.28.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  480.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  481.     7.29.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  482.     7.29.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  483.     7.29.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  484.     7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
  485.     7.29.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  486.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  487.     7.30.1 BY SYSTEM TYPE, 2025-2035 (USD Billion)
  488.     7.30.2 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
  489.     7.30.3 BY CHEMICAL OR BIOLOGICAL AGENT TYPE, 2025-2035 (USD Billion)
  490.     7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
  491.     7.30.5 BY END-USER TYPE, 2025-2035 (USD Billion)
  492.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  493.     7.31.1
  494.   7.32 ACQUISITION/PARTNERSHIP
  495.     7.32.1

Aerospace & Defense Market Segmentation

Aerospace & Defense By System Type (USD Billion, 2025-2035)

  • Detection
  • Protection
  • Decontamination

Aerospace & Defense By Equipment Type (USD Billion, 2025-2035)

  • Portable
  • Vehicle-Mounted
  • Fixed

Aerospace & Defense By Chemical or Biological Agent Type (USD Billion, 2025-2035)

  • Chemical Warfare Agents
  • Biological Warfare Agents
  • Radiological Warfare Agents

Aerospace & Defense By Application (USD Billion, 2025-2035)

  • Military
  • Law Enforcement
  • Emergency Response
  • Critical Infrastructure

Aerospace & Defense By End-User Type (USD Billion, 2025-2035)

  • Government
  • Commercial

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions